IDCases (Jan 2021)
Red face may be a specific sign of SARS-CoV-2 alpha variant
- Aya Nakaya,
- Eiji Ogura,
- Yuki Katayama,
- Masami Yoshii,
- Eiko Yoshino,
- Kazuya Hozumi,
- Saori Tago,
- Yuko Teranishi,
- Yuki Minamibashi,
- Makiko Harada,
- Mami Yoshioka,
- Yuri Kawano,
- Yuka Arai,
- Keno Yoshida,
- Shozo Shimizu,
- Kazuma Ogura,
- Katsuaki Iwashita
Affiliations
- Aya Nakaya
- Corresponding author.; Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Eiji Ogura
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Yuki Katayama
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Masami Yoshii
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Eiko Yoshino
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Kazuya Hozumi
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Saori Tago
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Yuko Teranishi
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Yuki Minamibashi
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Makiko Harada
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Mami Yoshioka
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Yuri Kawano
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Yuka Arai
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Keno Yoshida
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Shozo Shimizu
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Kazuma Ogura
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Katsuaki Iwashita
- Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu city, Shiga, 520-0232, Japan
- Journal volume & issue
-
Vol. 25
p. e01214
Abstract
Japan is currently suffering the fourth wave of the COVID-19 pandemic, with the dominant type being SARS-CoV-2 alpha variant. Patients with COVID-19 variant types show more aggressive symptoms. In the present study, three patients developed a red face during treatment. Two of them suddenly worsened shortly after. We assumed that the red face reflected a cytokine storm and conjectured that it may be a specific sign of variant type COVID-19, because we have never seen it in patients with non-variant type. Moreover, we believe that red face may be predictive of a sudden deterioration.